Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLOGIC INC Regulatory Filings 2021

Mar 12, 2021

30407_rns_2021-03-12_33fe4e13-697b-4586-8d7c-b1335df5e2ee.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____

FORM 8-K

____

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 11, 2021

____

HOLOGIC, INC.

(Exact Name of Registrant as Specified in Its Charter)

____

Delaware

(State or Other Jurisdiction of Incorporation)

1-36214 04-2902449
(Commission File Number) (I.R.S. Employer Identification No.)
250 Campus Drive,
Marlborough,
MA 01752
(Address of Principal Executive Offices) (Zip Code)

(508) 263-2900

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

____

Securities registered pursuant to Section 12(b) of the Act.

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $.01 par value HOLX The NASDAQ Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company’s Annual Meeting of Stockholders was held on March 11, 2021. Of the 257,661,792 shares outstanding and entitled to vote, 234,042,549 shares were represented at the meeting, constituting a quorum of 90.83%

All eight director nominees were elected to the Board for a one-year term.

In addition to electing directors, the stockholders:

a. provided advisory approval of the Company’s executive compensation (“say-on-pay”); and

b. ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 25, 2021.

The results of the votes for each of these proposals were as follows:

Proposal 1. Election of Directors

Nominees For Against Abstain Broker Non-Votes
Stephen P. MacMillan 204,838,081 17,590,121 1,984,460 9,629,887
Sally W. Crawford 210,906,233 13,383,640 122,789 9,629,887
Charles J. Dockendorff 218,787,401 5,492,734 132,527 9,629,887
Scott T. Garrett 215,759,071 8,521,741 131,850 9,629,887
Ludwig N. Hantson 219,959,953 4,318,798 133,911 9,629,887
Namal Nawana 219,887,382 4,396,261 129,019 9,629,887
Christiana Stamoulis 223,409,260 878,493 124,909 9,629,887
Amy M. Wendell 223,443,273 843,104 126,285 9,629,887

Proposal 2. Advisory approval of the Company’s executive compensation

For Against Abstain Broker Non-Votes
154,538,680 69,327,387 546,595 9,629,887

Proposal 3. Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered

public accounting firm for the fiscal year ending September 25, 2021

For Against Abstain
230,067,012 3,833,890 141,647

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 12, 2021
By: /s/ John M. Griffin
John M. Griffin General Counsel